Voyager Therapeutics CFO Nathan Jorgensen resigns; Robin Swartz named PFO, Amy Quinlan PAO

Voyager Therapeutics, Inc.

CFO Nathan Jorgensen, Ph.D. resigns effective May 8, 2026, to pursue new opportunity; no disagreement with company.
Board appoints Robin Swartz (COO/CBO) as principal financial officer and treasurer effective May 8, 2026.
Board appoints Amy Quinlan (VP Finance) as principal accounting officer effective May 8, 2026.
Swartz previously served as interim PFO and PAO in 2024; Quinlan joined in Jan 2025 from Vor Biopharma.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.